| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Brian Guan-Chyun Liu is Director at CGON. Brian Guan-Chyun Liu's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $120.8M at current prices.
Net of sales, the CGON filings show accumulation of 1,886,236 shares.
Brian Guan-Chyun Liu has 5 Form 4 filings on record from October 2024 to June 2026, all as Director at CG Oncology (CGON), 2024–2026.
The 5 reported transactions were 3 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $74.8M and no sales.
The largest open-market purchase was 1,515,151 shares of CGON at an average $33.00 on September 11, 2025, about $50.0M. Twelve months later CGON was up 118%.